Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 29.19B | 27.88B | 28.17B | 28.37B | 27.66B |
Gross Profit | 2.19B | 2.03B | 2.13B | 2.22B | 1.89B |
EBITDA | 3.50B | 3.19B | 3.25B | 3.43B | 3.12B |
Net Income | 1.50B | 1.37B | 1.35B | 1.44B | 1.19B |
Balance Sheet | |||||
Total Assets | 48.59B | 47.53B | 45.83B | 43.25B | 42.89B |
Cash, Cash Equivalents and Short-Term Investments | 6.35B | 6.56B | 8.33B | 7.67B | 6.44B |
Total Debt | 15.09B | 16.08B | 16.18B | 14.27B | 14.73B |
Total Liabilities | 21.94B | 22.34B | 22.59B | 21.07B | 21.74B |
Stockholders Equity | 26.65B | 25.20B | 23.24B | 22.17B | 21.15B |
Cash Flow | |||||
Free Cash Flow | 1.03B | -1.37B | -748.95M | 1.90B | 1.87B |
Operating Cash Flow | 3.24B | 1.81B | 2.65B | 2.83B | 3.08B |
Investing Cash Flow | -2.01B | -3.08B | -3.36B | -816.68M | -1.14B |
Financing Cash Flow | -1.44B | -508.71M | 1.37B | -783.14M | 237.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥11.46B | 7.59 | 3.32% | 4.56% | 30.80% | ||
77 Outperform | ¥8.70B | 6.56 | 1.92% | -1.60% | 45.60% | ||
76 Outperform | ¥14.66B | 10.69 | 3.40% | 3.56% | -14.38% | ||
76 Outperform | ¥11.93B | 9.41 | 3.87% | 2.66% | 25.68% | ||
73 Outperform | ¥7.06B | 15.82 | 0.93% | 5.99% | -7.07% | ||
71 Outperform | ¥4.88B | 8.81 | 1.63% | 3.00% | 86.86% | ||
64 Neutral | $10.96B | 16.35 | 8.89% | 1.96% | 2.68% | -15.17% |